POSITIVE RESULTS WILL PUSH THIS STOCK TO$6+ EASILY .GLTA
Bioniche life sciences ( BNC.TO )
Only 105 patients in current PhaseIII !!!!
Positive results from 2008 INVOLVING 130 PATIENTS !!!!
In November 2008,
during a meeting of urologists in Santigo Chile, the biopharmaceutical research company presented positive clinical studies (one and two) involving 130 bladder cancer patients treated with Urocidin. Elderly patients (average 73 years old) during the clinical studies noted excellent safety results
------------------------
Bioniche Phase III Clinical Trial With Urocidin(TM) Given Continued Green Light By DMC
The Data Monitoring Committee (DMC) held its ninth meeting regarding this clinical trial last week. After its meeting, the Committee has recommended that Bioniche "continue the trial unmodified until the next scheduled or triggered meeting."
The DMC is an independent group that acts in an advisory capacity to the Company. Its role is to evaluate the progress of the clinical trial, including monitoring the safety and efficacy data generated in the trial.
News 
Market Data 
Discover 
